世界の遺伝子検査市場動向...市場調査レポートについてご紹介

【英文タイトル】Genetic Testing Market Outlook 2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Analyst View
2. Research Methodology
3. Genetic Testing Overview
3.1 Application and Advantages
3.2 Methods
4. Global Genetic Testing Market Overview
4.1 Market Outlook
4.2 Genetic Testing Laboratories – Unmet Need Analysis
4.3 Direct-to-Consumer (DTC) Genetic Testing
5. Drivers & Challenges
5.1 Drivers
5.1.1 Increasing Public Awareness for Genetic Tests
5.1.2 Rising Incidence of Chronic Diseases
5.1.3 Growth in Ageing Population
5.2 Challenges
5.2.1 Decline in Fertility Rates
5.2.2 Ethical and Policy Issues
6. Disease-Wise Analysis
6.1 Alzheimer’s Disease
6.2 Cystic Fibrosis
6.3 Cancer
6.4 Bloom Syndrome
7. Country-Level Analysis
7.1 US
7.1.1 Market Overview
7.1.2 Recent Developments
7.2 Europe
7.2.1 Market Overview
7.2.2 Recent Developments
7.3 Asia-Pacific
7.3.1 Market Overview
7.3.2 Recent Developments
8. Emerging Sectors
8.1 Next-Generation Sequencing (NGS)
8.2 Non-Invasive Prenatal Testing (NIPT)
8.3 Whole Genome Sequencing (WGS) for Cancer
8.4 Personalized Medicine
9. Genetic Testing Regulation
10. Competitive Assessment
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Product Offering
10.1.3 Key Financials
10.1.4 Recent Developments
10.1.5 Strengths & Weaknesses
10.2 Roche Diagnostics
10.2.1 Company Overview
10.2.2 Product Offering
10.2.3 Key Financials
10.2.4 Recent Developments
10.2.5 Strengths & Weaknesses
10.3 Myriad Genetics, Inc.
10.3.1 Company Overview
10.3.2 Product Offering
10.3.3 Key Financials
10.3.4 Recent Developments
10.3.5 Strengths & Weaknesses
10.4 Thermo Fisher Scientific
10.4.1 Company Overview
10.4.2 Product Offering
10.4.3 Key Financials
10.4.4 Recent Developments
10.4.5 Strengths & Weaknesses
10.5 Agilent Technologies Inc.
10.5.1 Company Overview
10.5.2 Product Offering
10.5.3 Key Financials
10.5.4 Recent Development
10.5.5 Strengths & Weaknesses
10.6 Hologic, Inc.
10.6.1 Company Overview
10.6.2 Product Offering
10.6.3 Key Financials
10.6.4 Recent Developments
10.6.5 Strengths & Weaknesses
10.7 Illumina, Inc.
10.7.1 Company Overview
10.7.2 Product Offering
10.7.3 Key Financials
10.7.4 Recent Developments
10.7.5 Strengths & Weaknesses
10.8 Qiagen NV
10.8.1 Company Overview
10.8.2 Product Offering
10.8.3 Key Financials
10.8.4 Recent Developments
10.8.5 Strengths and Weaknesses
10.9 Cepheid
10.9.1 Company Overview
10.9.2 Product Offering
10.9.3 Key Financials
10.9.4 Recent Developments
10.9.5 Strengths and Weaknesses
10.10 Affymetrix, Inc.
10.10.1 Company Overview
10.10.2 Product Offering
10.10.3 Key Financials
10.10.4 Recent Developments
10.10.5 Strength and Weaknesses

List of Figures:

Figure 4-1: Genetic Testing Market (Billion US$), 2014-2020
Figure 4-2: Genetic Testing Market by Geography (%), 2014
Figure 4-3: Genetic Testing Market by Geography (%), 2020
Figure 7-1: Number of Disorders, Genes, Labs, & Clinics for Genetic Testing (2014 & 2015)
Figure 7-2: Number of Genetic Tests Performed (2013-2015)
Figure 7-3: US – Genetic Testing Market (Billion US$), 2014-2020
Figure 7-4: Europe – Genetic Testing Market (Billion US$), 2014-2020
Figure 7-5: Asia-Pacific – Genetic Testing Market (Million US$), 2014-2020
Figure 8-1: Global – Next Generation Sequencing Market (Billion US$), 2014-2020
Figure 8-2: Global – NGS Application by Sector (%)
Figure 8-3: Global – Next Generation Sequencing Market by Player (%), 2013
Figure 8-4: Global – Non-Invasive Prenatal Testing Market (Million US$), 2014-2020
Figure 8-5: US – Tapped and Untapped Personalized Cancer WGS Market (%), 2013
Figure 8-6: US – Personalized Cancer WGS Market (Million US$), 2014-2020
Figure 8-7: Organizational Transformation to Support Personalized Medicine
Figure 9-1: Genetic Testing Regulatory Agencies
Figure 10-1: Abbott Laboratories – Revenue Breakup by Segments (%), 2014
Figure 10-2: Abbott Laboratories – Revenue Breakup by Geography (%), 2014
Figure 10-3: Roche Holding – Revenue Breakup by Segments (%), 2014
Figure 10-4: Roche Holding – Diagnostic Division Revenue by Geography (%), 2014
Figure 10-5: Myriad Genetics – Revenue Breakup by Segments (%), 2014
Figure 10-6: Life Technologies – Revenue Breakup by Segments (%), 2014
Figure 10-7: Life Technologies – Revenue Breakup by Geography (%), 2014
Figure 10-8: Agilent – Revenue Breakup by Segments (%), 2014
Figure 10-9: Hologic – Revenue Breakup by Segments (%), 2014
Figure 10-10: Hologic – Revenue Breakup by Geography (%), 2014
Figure 10-11: Illumina – Revenue Breakup by Geography (%), 2014
Figure 10-12: Qiagen NV – Revenue Break up by Segments (%), 2014
Figure 10-13: Qiagen NV – Revenue Break up by Geography (%), 2014
Figure 10-14: Cepheid – Revenue Break up by Segments (%), 2014
Figure 10-15: Cepheid – Revenue Break up by Geography (%), 2014
Figure 10-16: Affymetrix – Revenue Breakup by Segments (%), 2014
Figure 10-17: Affymetrix – Revenue Breakup by Geography (%), 2014

List of Tables:

Table 4-1: Key DTC Genetic Testing Companies by Category
Table 4-2: Key Test Areas Offered in DTC Genetic Testing Segment
Table 7-1: FDA Approved Pharmacogenomic Biomarkers for Oncology
Table 9-1: Abbott Laboratories – Key Gene Based Products
Table 9-2: Abbott Laboratories – Financial Performance (Million US$), 2012-2014
Table 9-3: Roche Molecular Diagnostics – Key Gene Based Products
Table 9-4: Roche Holding – Financial Performance (Million US$), 2012-2014
Table 9-5: Myriad Genetics – Key Gene Based Products
Table 9-6: Myriad Genetics – Financial Performance (Million US$), 2012-2014
Table 9-7: Life Technologies – Key Gene Based Products
Table 9-8: Life Technologies – Financial Performance (Million US$), 2012-2014
Table 9-9: Agilent – Key Gene Based Products
Table 9-10: Agilent – Financial Performance (Million US$), 2012-2014
Table 9-11: Hologic – Key Gene Based Products
Table 9-12: Hologic – Financial Performance (Million US$), 2012-2014
Table 9-13: Illumina – Key Gene Based Products
Table 9-14: Illumina – Financial Performance (Million US$), 2012-2014
Table 9-15: Qiagen NV – Key Gene Based Products
Table 9-16: Qiagen NV – Financial Performance (Million US$), 2012-2014
Table 9-17: Cepheid – Key Gene Based Products
Table 9-18: Cepheid – Financial Performance (Million US$), 2012-2014
Table 9-19: Affymetrix – Key Gene Based Products
Table 9-20: Affymetrix – Financial Performance (Million US$), 2012-2014


【レポート販売概要】

■ タイトル:世界の遺伝子検査市場動向
■ 英文:Genetic Testing Market Outlook 2020
■ 発行日:2015年6月
■ 調査会社:RNCOS
■ 商品コード:RNCS50602
■ 調査対象地域:グローバル
  • PharmaSphere: Global Biosimilars Strategy – Regulatory Landscape, Key Drivers, Markets and Trends in 2013
    PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013 Summary GlobalData’s "PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013", provides strategic analysis of the global biosimilars industry. It discusses key market trends, regulatory requirements in various markets, recent deals activity an …
  • French Hospital Coagulation Testing Market 2014
    This new report from Venture Planning Group contains 398 pages, 29 tables, and presents a comprehensive analysis of the French hospital coagulation testing market, including:  Major issues pertaining to the French coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.&nb …
  • ブラジル/ロシア/インド/中国の尿路ステント処置動向(~2020)
    BRIC Urinary Tract Stenting Procedures Outlook to 2020 Summary GlobalData’s new report, "BRIC Urinary Tract Stenting Procedures Outlook to 2020", provides key market data on the BRIC Urinary Tract Stenting Procedures. The report provides procedure volumes within market segments - Ureteral Stenting Procedures (Unilateral and Bilateral Ureteral Stenting Procedures), Prostate Stenting Procedures (Pro …
  • ヘコゲニンの世界市場2015
    Hecogenin (CAS 467-55-0) Market Research Report 2015 aims at providing comprehensive data on Hecogenin market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Hecogenin description, covers its application areas, manufacturing methods, patterns. It captures Hecogenin market trends, pays close attention to Hecogenin manufacturers and names suppliers. Besi …
  • 再保険の世界市場
    About Reinsurance Reinsurance is “insurance for insurers.” It is a major risk-mitigation tool for insurers. In the wake of increasing incidence of catastrophic events and decreasing risk tolerance, reinsurance has become an indispensable part of the Insurance industry. By absorbing the losses of insurers, reinsurers help in the stabilization of the Insurance industry. They also help insurance play …
  • 世界の自動車用コンバーチブルルーフシステム市場:車両種類別、ルーフ種類別、地域別
    Global Automotive Convertible Roof System Market: About this market Technavio’s automotive convertible roof system market analysis considers sales from both soft top and hard roof top. Our study also finds the sales of automotive convertible roof system in APAC, Europe, MEA, North America, and South America. In 2019, the soft top segment had a significant market share, and this trend is expected t …
  • 乳タンパク質濃縮物の世界市場2019-2023
    About this market The increasing milk production is one of the growth drivers of the global milk protein concentrates market. The increasing number of dairy cows is also contributing to the increasing milk production globally. The number of dairy cows increased by about 6% between 2014 and 2016 in India. In the US. California had the highest number of dairy cows in 2018. The number of dairy cows i …
  • 世界の炎症性腸疾患(IBD)治療薬市場
    Treating Crohn’s disease and ulcerative colitis – how to find R&D trends, opportunities and revenue prospects What’s the future of medicines for inflammatory bowel disease (IBD)? Those intestinal treatments retain high potential. Now you can explore sales forecasts and that industry’s research and development. See there how that large, profitable market expands. Visiongain’s new investigation pred …
  • 非常照明の世界市場予測(~2022年)
    The emergency lighting market is expected to reach USD 6.68 Billion by 2022, at a CAGR of 7.83% between 2017 and 2022. The demand for emergency lighting is increasing because of several factors such as technological advancements taking place in the lighting industry, declining average selling price of LEDs, and increased infrastructure growth in various developing countries such as India, China, a …
  • Frontier Pharma: Systemic Lupus Erythematosus – Identifying and Commercializing First-in-Class Innovation
    Frontier Pharma: Systemic Lupus Erythematosus - Identifying and Commercializing First-in-Class Innovation Summary The Systemic Lupus Erythematosus (SLE) drug market is currently under-served by non-generic, targeted therapies. Whilst the only Food and Drug Administration (FDA)-approved biologic, Benlysta (belimumab), generated sales of $111m in 2012, there is little evidence that the drug’s perfor …
  • ノックアウトマウス・モデルの価格分析:指標、マウス種類、エンドユーザー、ディスカウント、契約、需要・供給、生理的特徴、ビジネスモデル、利害関係者分析
    Mice serve as appropriate study models for a variety of diseases because of their close genetic and physiological similarities to humans as well as the ease with which their genomes can be manipulated and analyzed. Knockout mice models are of paramount importance in biomedical researches which focus on finding cure for human diseases. Market players are continuously focusing on innovations in mice …
  • 日本の麻酔装置・呼吸装置市場
    Japan Anesthesia and Respiratory Devices Market Outlook to 2021 - Airway and Anesthesia Devices, Anesthesia Machines, Pain Management Devices, Regional Anesthesia Disposables, Respiratory Devices, Respiratory Disposables and Others Summary GlobalData’s new report, "Japan Anesthesia and Respiratory Devices Market Outlook to 2021 - Airway and Anesthesia Devices, Anesthesia Machines, Pain Management …
  • Alcon, Inc.:市場シェア分析
    Alcon, Inc. Market Share Analysis Summary GlobalData’s new report, “Alcon, Inc. Market Share Analysis” provides in-depth information on Alcon, Inc.’s market position in the different medical equipment markets it operates in. The report provides Alcon, Inc. market share information in six key market categories – Cataract Surgery Devices, Glaucoma Surgery Devices, Intraocular Lens (IOL), Refractive …
  • 世界のフレキシブルディスプレイ市場動向(2012-2016)
    TechNavio's analysts forecast the Global Flexible Displays market to grow at a CAGR of 45.4 percent over the period 2012-2016. One of the key factors contributing to this market growth is the high demand for flexible displays in smartphones and tablet computers. The Global Flexible Displays market has also been witnessing the rapid technological advancement. However, lack of technology standards c …
  • 小規模液化天然ガス(LNG)の世界市場:小規模再ガス化、小規模液化、LNGサテライトステーション、LNG積込設備、LNG燃料補給施設
    Visiongain identifies LNG import terminals and liquefaction plants as small scale if their regasification or liquefaction capacity is less than 1 mtpa. Other elements of the small scale LNG market are bunkering facilities used by LNG fuelled vessels, infrastructure to supply LNG as a fuel for road vehicles and LNG satellite stations. Historically, LNG is produced by large scale liquefaction plants …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。